GNTA · Genenta Science SpA ADR
United States · RS rating 56 · As of 2026-11-03
| Price | 0.98 USD |
|---|---|
| 1-day change | +20.6% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 97 / 25 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 18 / 8 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +61.5% |
| Market cap (USD) | $16.6M |